MatchaDB

2021学術論文無料で読める

Matcha Green Tea Alleviates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating Lipid Metabolism and Inflammatory Responses.

Zhou J, Yu Y, Ding L, Xu P, Wang Y

Nutrients

出版社で読む→無料の全文→PubMedPubMed Central

要旨

Lately, matcha green tea has gained popularity as a beverage and food additive. It has proved to be effective in preventing obesity and related metabolic syndromes. However, the underlying mechanisms of its control effects against non-alcoholic fatty liver disease (NAFLD) are complicated and remain elusive. In the present study, we performed an in vivo experiment using male C57BL/6 mice fed with a high-fat diet and simultaneously treated with matcha for six weeks. Serum biochemical parameters, histological changes, lipid accumulation, inflammatory cytokines, and relevant indicators were examined. Dietary supplementation of matcha effectively prevented excessive accumulation of visceral and hepatic lipid, elevated blood glucose, dyslipidemia, abnormal liver function, and steatosis hepatitis. RNA sequencing analyses of differentially expressed genes in liver samples indicated that matcha treatment decreased the activity of lipid droplet-associated proteins and increased the activity of cytochrome P450 enzymes, suggesting improved metabolic capacity and liver function. The current study provided evidence for new dietary strategies based on matcha supplementation to ameliorate lipotoxicity-induced obesity and NALFD.

要旨の文章はPubMed、OpenAlex、Europe PMCから取得したもので、著者と出版社に帰属します。

研究の種類

動物研究

マウス、ラット、魚などの動物での実験。

タイトル、要旨、件名から自動的に割り当てています。

トピック

ここでは抹茶が主題のひとつです(タイトルに記載)。

キーワードと件名

あなたのリサーチフォルダー

この研究を引用する

Zhou J, Yu Y, Ding L, Xu P, Wang Y. (2021). Matcha Green Tea Alleviates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating Lipid Metabolism and Inflammatory Responses. Nutrients. https://doi.org/10.3390/nu13061950

DOI: 10.3390/nu13061950 · PubMed ID: 34204055 · 被引用54件(OpenAlex)

代謝と体重についてさらに

2018学術論文

Effect of tea products on the in vitro enzymatic digestibility of starch.

Zhang H, Jiang Y, Pan Jほか — Food chemistry

The importance of postprandial hyperglycemia in the treatment of diabetes has been recognized recently. Tea products, such as tea polyphenols (TP), epigallocatechin gallate (EGCG), matcha, and instant tea, were chosen as constituents of…

試験管内・細胞研究代謝と体重抗酸化物質とポリフェノール腸とマイクロバイオーム被引用76回
2018学術論文無料で読める

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

試験管内・細胞研究代謝と体重抗酸化物質とポリフェノールがん被引用75回
2020学術論文

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJほか — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

動物研究代謝と体重腸とマイクロバイオーム市場・文化・持続可能性被引用74回

ライブラリ全体を見る→